- 专利标题： Substituted quinoxalines as FGFR kinase inhibitors
-
申请号： US13990193申请日： 2011-11-29
-
公开(公告)号： US09145394B2公开(公告)日： 2015-09-29
- 发明人: Gordon Saxty , Christopher William Murray , Valerio Berdini , Gilbert Ebai Besong , Christopher Charles Frederick Hamlett , Steven John Woodhead , Yannick Aime Eddy Ligny , Patrick René Angibaud
- 申请人： Gordon Saxty , Christopher William Murray , Valerio Berdini , Gilbert Ebai Besong , Christopher Charles Frederick Hamlett , Steven John Woodhead , Yannick Aime Eddy Ligny , Patrick René Angibaud
- 申请人地址： GB Cambridge
- 专利权人： ASTEX THERAPEUTICS LTD
- 当前专利权人： ASTEX THERAPEUTICS LTD
- 当前专利权人地址： GB Cambridge
- 代理机构： Heslin Rothenberg Farley & Mesiti P.C.
- 优先权： GB1020179.6 20101129
- 国际申请： PCT/GB2011/052356 WO 20111129
- 国际公布： WO2012/073017 WO 20120607
- 主分类号： A61K31/498
- IPC分类号： A61K31/498 ; C07D241/40 ; C07D403/04 ; C07D401/14 ; C07D403/14
摘要：
The invention relates to new quinoxaline derivative compounds of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
公开/授权文献
- US09290478B2 Substituted quinoxalines as FGFR kinase inhibitors 公开/授权日：2016-03-22
信息查询
IPC分类:
